Regorafenib offers survival benefit for patients with pre-treated gastric cancer Presented ByProf. Nick Pavlakis, University of Sydney, Australia TrialPhase 3, INTEGRATE IIa ConferenceASCO GI 2023 17 March, 2023 08:24